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stents. Single and OL SES eluted > 90% of sirolimus loaded by Day 60. Sirolimus
elution rate and arterial content in all 3 cohorts declined quickly to similar levels by
Day 3. Though OL NEVO™ stents eluted 3.7-fold more sirolimus than single NEVO™
stents by Day 1 (28.8±7.4 vs 7.7±3.1 μg), arterial content was not statistically different,
indicating that local drug delivery to the artery wall from OL SES is dominated by the
wall-apposed stent. This inference is supported by the fact that peak sirolimus blood
level in OL NEVO™ and OL 2x-NEVO™ stents was 5.5- to 9.8-fold higher than single
NEVO™ stents (3.31±1.13 and 5.89±1.75 vs 0.60±0.27 ng/ml). Sirolimus levels in
blood, myocardium, and peripheral organs declined below the limit of quantification
by Day 60.
Conclusion: Our data show that overlapping NEVO™ stents do not influence
sirolimus elution rate and that wall apposition dominates local arterial delivery.
Systemic sirolimus exposure remains below toxic levels at all times even for OL 2x-
NEVO™ stents, presumably due to fast hydrolytic degradation of free sirolimus in
blood and hepatic metabolism.
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Background: Previous research from our group has demonstrated trioxide (As2O3)
eluting stents (AESs) significantly reduced neointimal area and thickness compared
with bare metal stents . In the present study, we explored the anti-inflammatory effect
of As2O3 in vitro and in vivo for understanding the mechanism of AESs in reducing
in-stent restenosis.
Methods: Human dendritic cells and T lymphocytes were co-cultured with different
concentrations of As2O3. Effect of As2O3 on apoptosis, phenotypic characterization,
and cytokines production of these two kinds of inflammatory cells were evaluated by
flow cytometry and enzyme-linked immunosorbent assays. Sixty-five pigs underwent
placement of 139 oversized stents in the coronary arteries with histologic analysis,
As2O3 levels evaluation, endothelial function analysis, immunohistochemical and
western blot analysis.
Results: As2O3 induced apoptosis of human T lymphocytes and dendritic cells in a
dose-dependent manner. AESs induced less foreign body reactions of fibrin-platelet
deposition and acute inflammatory cells infiltration than BMSs and polymer-coated
stents (PCSs). There was no significant difference in extensive endothelialization and
endothelial function between AESs and BMSs after 4 weeks post stent implantation.
Stent-based As2O3 delivery effectively inhibited expression of inflammation-
associated proteins such as monocyte chemoattractant protein-1 (MCP-1) and
interleukin-6 (IL-6), in agreement with the western blotting results.
Conclusion: As2O3 eluting stents favorably modulate neointimal formation 4 weeks
after stent implantation. The quick elution of the drug from the biodegradable coating
material, less augmentation of early inflammatory reactions, and quick
endothelialization of the stent surface might contribute to the long-term safety and
efficacy.
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Background: Optical coherence tomography (OCT) has the ability to detect small
changes in peri-strut neointimal formation, however, its ability to characterize tissue
types is still limited. In this study, we aimed to compare different characteristics of in-
stent neointimal tissue in OCT with types analyzed by histology.
Methods: A total of 69 stents [39 DES and 30 BMS] were implanted in coronary
arteries of 27 swine. By OCT, neointimal type was classified as homogeneous,
heterogeneous or layered pattern according to its pattern of backscatter and optical
density. These resulting optical patterns were correlated with histological findings
(external elastic lamina (EEL) disruption, significant fibrin deposition, circumferential
rim of peri-strut inflammatory cell infiltration and collagen deposition) in every cross-
section (CS).
Results: A total of 197 OCT and histological CS were well matched. The
heterogeneous (0.44±0.21mm) and layered (0.65±0.16mm) patterns had a significantly
higher degree of neointimal thickness compared to the homogeneous pattern
(0.25±0.16 mm, p<0.001). Collagen deposition was more frequently present in the
homogeneous pattern (72%), whereas significant fibrin deposits were more commonly
seen in the heterogeneous pattern (57%). Peri-strut inflammation was less frequently
found in the homogeneous pattern (19.8%) in comparison to the layered (73.9%) or
heterogeneous patterns (43.1%). Presence of EEL rupture behaved similarly (73.9%
in layered, 46.6% in heterogeneous, 22.4% in homogeneous pattern). Optical density
analyses showed that the homogeneous pattern had the narrowest standard deviation
(0.09±0.10 vs. 0.26±0.22 in heterogeneous and 0.42±0.24 in layered pattern) and the
highest mean value (105.9±17.6 vs. 83.0±17.1 in heterogeneous and 84.0±12.9 in
layered pattern).
Conclusion: The optical characteristics of neointimal formation seen in OCT properly
correlated with the presence of several histological findings involved in stent healing.
The biological implications of these findings in clinical outcomes require further
investigation.
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Background: Conventional metallic, drug-eluting stents (DES) restrict restenosis after
percutaneous coronary intervention (PCI). However, stents can generate additional
foreign body reactions and consequently increase the possibility of adverse
events.Bioresorbable polymeric scaffolds have been suggested as a possible solution.
In this study, short-term effects of fully bioabsorbable sirolimus-loaded poly-l-lactic
acid (PLLA) stents (Xinsorb) were evaluated in a porcine coronary model to assess
the technical feasibility, biocompatibility, and effects on coronary stenosis.
Methods: PLLA stents (Xinsorb, Huaan Biotechnology Co., Ltd, China) were coated
with 140 μg/cm2 of sirolimus. Commercially available sirolimus-eluting stents (Excel,
JW Medical System, China) were used as controls. Xinsorb stents (n=16) and Excel
stents( n=16) were randomly implanted in porcine coronary arteries. Neointima
formation was measured by angiography and histomorphometry at 30 and 90 days.
Additionally,inflammation score and endothelial cell recovery were measured.
Results: The Xinsorb stents can be delivered and expanded at high pressure compared
with Excel stents, without any fracture and acute recoil. Both had a remarkable effect
on reducing neointimal hyperplasia,since no distinctive vessel narrowing greater than
50% were observed by angiography.By histomorphometry,at 30 and 90 days, coronary
stenosis was 18.6 ± 5.2 vs. 21.4 ± 7.2% and 24.5 ± 4.7 vs. 27.7 ± 5.6% respectively (p
> 0.05), after Xinsorb and Excel stent implantations. The inflammation scores were
0.84 ± 0.15 vs. 0.74 ± 0.10 and 0.93 ± 0.26 vs. 0.88 ± 0.10, respectively (p > 0.05). At
90 days, through scanning electron microscopy, Xinsorb and Excel stents were all
completely endothelialized, though they mildly delayed reendothlialization at 30 days.
Conclusion: Xinsorb stents reliably supported blood vessels and favourably modulated
neointimal formation at least at 90 days in a porcine coronary model. No safety
concerns regarding inflammatory reactions and in-stent thrombosis were observed.The
long-term safty and efficacy of the stents will be validated.
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Background: The Svelte Stent-on-a-Wire (SOAW) is a thin strut novel device
consisting of a balloon expandable cobalt chromium stent premounted onto a single
lumen fixed-wire delivery catheter platform. We evaluated the performance of the novel
Svelte Stent-on-a Wire, in comparison with the MultiLink Vision (ML Vision) balloon
expandable stent, in porcine coronary arteries.
Methods: Eight Yorkshire swine (30-day follow-up cohort) and 7 Yucatan mini-swine
(90-day follow-up cohort) were implanted with either Svelte SOAW or control ML
Vision. Acute performance characteristics were graded by interventionalists during
implantation. Angiographic assessments were performed at the index procedure and
at 30 or at 90 days post-implantation. Scanning electron microscopy (SEM) histological
and histomorphometric analysis of stented segments were performed after angiographic
follow-up.
Results: Acute implantation performance was similar between the 2 stents however
deflation time was significantly lower in the Svelte SOAW group (9.56±0.96 s vs
4.70±0.93 s, p < 0.05). Angiographic late loss was similar for both stents at 30
(0.83±0.59 mm vs 0.88±0.71mm, p=0.969) and at 90 days (0.76±0.35 mm vs
0.83±0.35 mm, p=0.679). SEM analysis showed complete endothelialization at 30 days
in both stent types. The presence of inflammatory cells was minimal and equivalent
for both stent treatments at both time points. There was no in-stent thrombus in either
stent group. Histopathological assessment demonstrated minimal injury and equivalent
inflammation at 30 and 90 days with Svelte SOAW and ML Vision stents as well as
endothelialization, neointimal maturation, adventitial fibrosis and neointimal fibrin.
Histomorphometric analysis showed no differences between the 2 groups in stent,
lumen, media or neointimal areas at either 30 or 90 days post-implantation.
Conclusion: At 30 and 90 days after implantation in porcine coronary arteries, the
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Svelte Stent-on-a-Wire showed vascular healing and tissue response equivalent to that
observed with ML Vision stents.
TCT-448
Scanning Electron Microscopic Observation of Coating Irregularities and Their
Precursors in Unexpanded Durable Polymer-Based Drug-Eluting Stents
Mounir W.Z. Basalus1, Kenneth Tandjung1, Hanim Sen1, Thea van Westen2, Dirk W
Grijpma2, Aart A van Apeldoorn2, Clemens von Birgelen1, 2
1MST hospital, Departement of Cardiology., Enschede, Netherlands; 2MIRA –
Institute for Biomedical Technology and Technical Medicine, University of Twente.,
Enschede, Netherlands
Background: Previous scanning electron microscopy (SEM) studies in expanded DES
revealed differences in the frequency and size of coating irregularities between DES
types and specific distribution patterns, however, the origin of these irregularities is
unclear.The current study quantifies coating irregularities on unexpanded and expanded
durable polymer-based drug-eluting stents (DES) to gain insights into the potential
origin of coating irregularities.
Methods: We assessed at bench side a total of 1200 SEM images obtained in 30 DES
samples (15 expanded and 15 unexpanded) of Cypher Select, Taxus Liberté, Endeavor,
Xience V, and Resolute.
Results: For most types of coating irregularities seen on expanded DES (72%; 23/32),
a matching irregularity (n=18/24) and/or its precursor (n=11/24) was observed in
unexpanded corresponding DES. Only a few individual coating irregularities (13%;
4/32) could not be accessed in unexpanded samples, as these irregularities were located
on the (invisible) luminal side. Unexpanded Cypher Select showed (small) crater
lesions and cracks together with precursors of ‘peeling of polymer’. On unexpanded
Taxus Liberté, thinning of polymer, small bare metal areas, wrinkles and one type of
precursor was found. Unexpanded phosphorylcholine-based Endeavor stents showed
cracks, small bare metal areas, and crater lesions as well as precursors of the latter.
Unexpanded Xience V and Endeavor Resolute mainly revealed crater lesions and their
precursors.
Cypher Stent:Precursor of peelin (left); peeling (right)
Conclusion: SEM assessment demonstrated the presence of various coating
irregularities and/or their precursors on unexpanded durable polymer-based DES.
These findings provide evidence that coating irregularities arise during both DES
manufacturing and stent expansion.
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Background: The Polymeric Bioresorbable Myolimus-Eluting Scaffold is a novel drug
eluting device that combines a PLLA-based scaffold coated with a matrix of
bioresorbable polylactide and the drug Myolimus. Myolimus is a macrocyclic lactone
mTOR inhibitor similar to rapamycin (sirolimus) which has demonstrated potent anti-
proliferative properties in cell culture studies and successfully used in two First-in-Man
(FIM) studies on Elixir’s Myolimus eluting coronary stents. The drug dose is 3 mcg
per mm of scaffold length, similar to the dose used in the prior Elixir FIM studies.
Multiple radiopaque markers are located on each end of the scaffold to aid delivery
and placement in vivo. The objective of this study was to evaluate the safety and
efficacy of the Polymeric Bioresorbable Myolimus-Eluting Scaffold in a preclinical
model.
Methods: Polymeric Bioresorbable Myolimus-Eluting Scaffolds were implanted in
swine coronary arteries and evaluated over a period of 28, 90 and 180 days. Analyses
by OCT and histopathology were employed to evaluate the safety and efficacy of the
scaffolding systems. Pharmacokinetics (PK) of the drug from the scaffold was
measured using standard analytical techniques.
Results: The preclinical results of the Polymeric Bioresorbable Myolimus-Eluting
Scaffold implanted in the porcine coronary artery model are presented in the table
below. All vessels were patent after the evaluation period with histopathology profiles
expected for drug eluting stents. The PK analysis of the scaffold and tissue surrounding
the scaffold showed that approximately 80% of drug is released over a 28 day period.
Conclusion: The preclinical evaluation of the Polymeric Bioresorbable Myolimus-
Eluting Scaffold demonstrated safety and effectiveness in support of a First-in-Man
study.
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Background: Deficiency of the glutathione peroxidase-1 (GPx1) is associated with
in-stent stenosis (ISS).
Methods: We used a novel genome-wide gene expression network approach in human
atherectomy samples comparing atherosclerosis to ISS (n=89) to identify signaling
networks critical to the process of ISS. We found that a subnetwork with GPx1 as its
hub was among the most significantly differentially regulated (Fig 1, bar thickness
denotes association strength). We investigated the importance of Gpx1 in ISS using
knockout mice with constitutive deficiency of GPx1 crossed onto atherosclerotic ApoE-
KO background using a novel model of balloon angioplasty and stenting (BAS) in
mice.
Results: ApoE-KO mice had significantly decreased Gpx1 expression compared to
atherosclerosis. Despite equal stent expansion and injury scores, ISS was increased by
50% on histological cross-section (P<0.01) and 33% per-stented vessel longitudinally
by OCT (P<0.01) in GPx1/ApoE-KO mice 28 days following BAS (Fig 2, white arrows
denote neointima). In keeping with this, both proliferation (71%, P<0.01) and migration
(90%, P<0.01) were significantly increased in GPx1/ApoE-KO primary aortic smooth
muscle cells compared to ApoE-KO. In animals with additional targeted endothelial
reporter gene expression (Tie2-LacZ) we found Gpx1/ApoE-KO/LacZ mice had
significantly reduced endothelial coverage (58%, P=0.03) compared with ApoE-
KO/LacZ mice, suggesting impaired reendothelialization as a potential mechanism by
which Gpx1/ApoE-KO mice have increased ISS.
Conclusion: Using a network analysis approach we have identified an important role
for GPx1 signaling in vascular wall redox processes critical to ISS.
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Background: Transseptal access is routinely used for cardiological procedures in the
left heart, but not yet to access the aortic arch and its branches. Iliac and aortic
pathology such as obstruction and tortuosity may require antegrade access to advance
and deploy an endograft in the proximal parts of the thoracic aorta. The aim of the
present study was to test the feasibility of antegrade transseptal access to the ascending
aorta for stent-graft introduction and placement using a through-and-through guidewire
technique in a porcine model.
Methods: Transseptal puncture was performed in 6 domestic pigs (51-58kgBW) from
the inferior vena cava for guidewire-passage across the left heart to the descending
aorta to establish transseptal through-and-through access. Custom-made endografts
consisting of polyester-tube and two nitinol-stents (diameter 24mm, length of 32mm)
were advanced using the transvenous antegrade access and deployed under fluoroscopy
into the ascending aorta using a pull-and-push technique with moderate tension on the
wire. Hemodynamic monitoring (PiCCo catheter, Swan-Ganz catheter), transit-time
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